REFILE-BUZZ-U.S. stocks weekly: Shot in the arm
(Corrects typo in 1st bullet) ** S&P 500 on 3-week winning streak, finishes up 1.2% on optimism over an eventual coronavirus vaccine ** That said, the SPX may be on a countdown to a downward reversal ** This as the Nasdaq may have flamed out ** Nevertheless, the SPX did see an exuberant pop, enough to probe to a fresh 5-month high ** Most sectors gain: Industrials, materials and healthcare surge, while tech and consumer discretionary sag; indeed, when it comes to growth vs. value, growth may finally be out of steam ** Industrials jump 5.8%. J.B. Hunt Transport trucks to fresh record high after results beat . Dow Transports accelerate >6% ** Healthcare climbs 5.1%. Pfizer advances on FDA's 'fast track' status for two experimental coronavirus vaccines. Nasdaq Biotech index up 3.5% ** Financials gain 2%. JPMorgan kicks off Q2 on upbeat note, Wells Fargo hit by dividend cut . Goldman Sachs rises as trading, underwriting gains boost profit. Bank of America dips on net interest income weakness, Morgan Stanley impresses ** Communication services fall 0.9%. Netflix tumbles as Q3 subscriber forecast disappoints . Twitter slides Thurs after co says hackers accessed internal systems ** Tech drops 1.2%. Chipmaker Analog Devices falls on ~$21 bln buy of rival Maxim Integrated Products Inc in largest M&A deal this year ** Consumer discretionary slumps 1.6%. Norwegian Cruise Line declines on $1.4 bln capital refuel . Though hotel and online travel stocks rise after Moderna Inc's potential COVID-19 vaccine shows promising data ** Meanwhile, profit expectations still weak, but not getting worse, and V or L? The economy has poor penmanship ** SPX performance YTD: (Lance Tupper and Terence Gabriel are Reuters market analysts. The views expressed are their own)
